Assenagon Asset Management S.A.
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in AMRX
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$42,332,453
+$4,205,156 QoQ
Shares Held
2,445,549
-20.3% QoQ
Ownership
0.767%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1
of 26 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $514,912,865 across 20 Drug Manufacturers - Specialty & Generic names. AMRX ranks #6 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,056,017 | $103,537,855 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
714,980 | $79,319,881 | |
| 3 | VTRS |
Viatris Inc
|
4,989,006 | $79,225,415 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,540,928 | $63,224,275 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
84,538 | $45,805,224 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
2,445,549 | $42,332,453 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
222,606 | $37,518,015 | |
| 8 | ZTS |
Zoetis Inc.
|
389,335 | $27,977,613 |
All Filings in AMRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,332,453 | 2,445,549 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $38,127,297 | 3,067,361 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $47,397,911 | 3,761,739 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $21,521,910 | 2,150,041 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $6,058,204 | 748,851 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $6,869,387 | 819,736 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $6,022,914 | 760,469 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $10,025,550 | 1,204,994 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $3,574,599 | 562,929 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $3,312,014 | 546,537 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $892,563 | 147,045 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $2,174,283 | 515,233 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $718,297 | 231,709 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $373,447 | 268,667 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $144,430 | 72,578 | Shares | Sole | 2023-01-12 | |
| 2021-09-30 | $157,620 | 29,517 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $151,127 | 29,517 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,644,812 | 244,400 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,132,103 | 247,725 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $72,168 | 18,600 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $3,071,723 | 645,320 | Shares | Sole | 2020-07-21 | |
| No filing history on record for this holder in this stock. | ||||||